Fireside Chat with Medical Device Leaders from Johnson & Johnson Innovation

Oct 6 2016https://www.eventbrite.com/e/fireside-chat-with-medical-device-leaders-from-john...

We know what you, the innovator, need to get your science to patients. It is because of YOU that Johnson & Johnson Innovation (JJI) created regional centers that host a team of science and transaction experts whose goal is to find high potential early-stage (pre-clinical proof-of-concept) innovation and help accelerate the science to the patient. The JJI team has broad deal-making capabilities with the flexibility to adapt the deal structures to the science, across the Pharmaceutical, Medical Devices and Consumer healthcare segments.

Johnson & Johnson's Medical Device business is one of the largest in the world. J&J produces a broad range of innovative products in the field of orthopedics, neurovascular, surgery, vision care, diabetes care, infection prevention, cardiovascular disease, sports medicine, and aesthetics.

Hear from leaders from Johnson & Johnson's Medical Device sector as they discuss J&J's areas of interest when it comes to devices, how we evaluate early-stage science, and what is in store for the future of medical devices.

Don't miss the opportunity to apply for a one-on-one meeting with these experts as a forum to further discuss your company. To be considered for a one-on-one meeting, please email your one-page non-confidential summary to V. Kadir Kadhiresan, by Monday, September 26th.


Speakers:
Dana Deardorff | Sr. Director, New Ventures, Johnson & Johnson Innovation read bio»
Bethany Grant | Director R&D, Surgical Innovation, Ethicon, Inc. read bio»
V. Kadir Kadhiresan | VP, Venture Investments, Johnson & Johnson Innovation - JJDC read bio»
[moderator] Stephen McCarthy | Co-Director, M2D2-Massachusetts Medical Device Development Center; Professor, University of Massachusetts Lowell read bio»


Agenda:
10:00 AM | Registration Opens, Networking
10:30 AM | Panel Discussion
11:30 AM | Q&A
11:45 AM | Networking Lunch
12:30 PM | Program Close
12:30-5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on September 26th, 2016.


Fees:
Panel & Lunch
FREE | M2D2 Residents
$10 | General Public
$20 | At the door
Includes panel, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the panel, Q&A, and lunch will remain open until noon on October 5th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time and be approved. To be considered for a one-on-one meeting, please email your one-page non-confidential summary to V. Kadir Kadhiresan, by Monday, September 26th.


Location:
M2D2
110 Canal Street
4th Floor
Lowell, MA 01852


Speakers' Biographies:

Dana Deardorff, Ph.D. | Senior Director, New Ventures, Johnson & Johnson Innovation
Dana Deardorff, Ph.D. recently joined Johnson & Johnson Innovation as the Senior Director of New Ventures for medical devices. In this role, Dana is responsible for developing and investing in early-stage technologies of strategic interest across the medical device sector within J&J. Dana has over 20 years of experience in the medtech industry in various roles bridging technology and business. Previously he worked for Covidien in several leadership positions including VP of Advanced Technology, Strategy & Portfolio Management, and Business Development. Dana has also been an entrepreneur, starting multiple companies as a co-founder and leading technology and product development activities. Most recently he served as an Entrepreneur-in-Residence and advisor to the University of Illinois, helping to evaluate and accelerate the commercial potential of innovative technologies. Dana has a joint doctorate in biomedical engineering from UC-Berkeley and UC-San Francisco and a bachelor's degree in physics from Illinois Wesleyan University.
Connect with Dana:   Connect on LinkedIn



Bethany Grant | Director R&D, Surgical Innovation, Ethicon, Inc.
Bethany Grant is the R&D Director of Surgical Innovation for Metabolics at Ethicon, a company in the Medical Device division of Johnson & Johnson. In this role she is working to identify unmet needs in metabolic diseases and obesity and to develop treatments that address these needs. Bethany started her career in the Aerospace Industry; after completing her B.S. and M.S. in Aero/Astro Engineering at MIT, she spent time at Boeing Defense and Space and Loral Space Systems designing composite structures for helicopters and satellites. Through her work at a product development consulting firm focusing mainly on the healthcare industry, Bethany helped launch a custom dental abutment from concept to a successful business solution and acquisition by AstraZeneca. After the integration, Bethany joined J&J with the orthopedic business, spending 5 years with DePuy Synthes Mitek Sports Medicine. In this role, she developed minimally invasive orthopedic procedural solutions for joint soft tissue repair, with a focus on hip arthroscopy. Bethany has worked for over 20 years in all phases of product development, from early stage to launch, and in many sizes of organizations.
Connect with Bethany:   Connect on LinkedIn



V. Kadir Kadhiresan, Ph.D. | Vice President, Venture Investments, Johnson & Johnson Innovation - JJDC
V. Kadir Kadhiresan, Ph.D. joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2007. He serves on the boards of JJDC portfolio companies and is based in Boston, Massachusetts. Dr. Kadhiresan has more than a decade of operational experience in various functional roles including research, product development, and business development. Before joining JJDC, as head of Business Development at Guidant, Inc., now Boston Scientific, Inc., Dr. Kadhiresan led several transactions to access novel medical device technologies with venture investments, M&As, licensing and joint ventures. Prior to entering business development, he led the research and development of multiple early-stage technologies and products in cardiac rhythm management and heart failure. Dr. Kadhiresan was instrumental in the development of the cardiac resynchronization therapy for heart failure, now a multi-billion dollar market,worldwide. At Heart Rhythm Technologies, a subsidiary of Guidant, he led the development of an ablation technology for treatment of atrial fibrillation and raised venture financing for the project. In addition, Dr. Kadhiresan is an inventor on more than 40 patents and has published several articles in peer-reviewed journals. Dr. Kadhiresan received a Ph.D. and Master of Science in Biomedical Engineering from the University of Michigan, Ann Arbor, a Master of Business Administration from the Kellogg School of Management at Northwestern University, and a Bachelor of Science in Electrical Engineering from National Institute of Technology (REC), Trichy, India.
Connect with V. Kadir:   Connect on LinkedIn



[moderator] Stephen McCarthy | Co-Director, M2D2-Massachusetts Medical Device Development Center; Professor, University of Massachusetts Lowell
Dr. Stephen McCarthy is a faculty member of the Plastics Engineering Department at UMass Lowell. He is currently the Co-Director of the Massachusetts Medical Device Development Center at UMass Lowell and UMass Worcester and Director of the Biodegradable Polymer Research Center where he is conducting research into Biodegradable Polymers and Blends. He is the Editor for the "Journal of Polymers and the Environment." He received his B.S. from Southeastern Massachusetts University, a Masters in Chemical Engineering from Princeton University, and a Ph.D. in Macromolecular Science from Case Western University in Cleveland, Ohio. He worked as an Advanced Engineer in R&D for Owens Corning Fiberglas in Granville, Ohio.
Connect with Stephen:   Connect on LinkedIn


Share